Definitive Healthcare Corp. 8-K

What Happened

• Definitive Healthcare Corp. (DH) filed an 8-K on June 24, 2026 reporting that on June 18, 2026 Nasdaq’s Listing Qualifications Department notified the company it no longer meets the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1).
• Nasdaq determined the deficiency based on the closing bid price over 30 consecutive business days from May 6, 2026 to June 17, 2026. The company has a 180-calendar-day compliance period (until December 15, 2026) to regain compliance.

Key Details

• Notice date: June 18, 2026; 8-K filed June 24, 2026.
• Deficiency period: closing bid price for May 6–June 17, 2026 (30 consecutive business days) below $1.00.
• Compliance path: regain a closing bid of at least $1.00 for a minimum of 10 consecutive business days to cure the deficiency; Nasdaq may require longer.
• If not cured, the company may be eligible for a second 180-day period only if it meets market value/public float and other initial listing standards for The Nasdaq Capital Market and notifies Nasdaq (the company could effect a reverse stock split if necessary). Trading of DH remains active during the compliance period.

Why It Matters

• This notice signals a potential delisting risk if the company cannot raise its share price to meet Nasdaq’s minimum bid requirement. Delisting or prolonged non-compliance can reduce liquidity and make the stock harder to trade.
• The company may pursue options such as a reverse stock split to regain compliance, but the 8-K states there is no assurance compliance will be achieved. Investors should monitor DH’s closing bid price, company announcements, and any proposed corporate actions.